Jesper Petersson (@jespertwi29) 's Twitter Profile
Jesper Petersson

@jespertwi29

ID: 4844956114

calendar_today25-01-2016 09:33:03

147 Tweet

50 Takipçi

25 Takip Edilen

Jesper Petersson (@jespertwi29) 's Twitter Profile Photo

Diverging Trends in the Incidence of Spontaneous Intracerebral Hemorrhage in Sweden 2010–2019: An Observational Study from the Swedish Stroke Register (Riksstroke) | Neuroepidemiology | Karger Publishers karger.com/ned/article/do…

Jens Fiehler (@fie0815) 's Twitter Profile Photo

Effect of reperfusion in large core stroke: it is edema reduction (66%), penumbra salvage plays a smaller role (22%). ⁉️Any consequences for imaging selection? @WBrinjikji @DGNR_org ESMINT Society TENSION Study @eso World Stroke Org doi: 10.1002/ana.26802.

Effect of reperfusion in large core stroke: it is edema reduction (66%), penumbra salvage plays a smaller role (22%). ⁉️Any consequences for imaging selection? @WBrinjikji @DGNR_org <a href="/esmintsociety/">ESMINT Society</a> <a href="/TENSIONstudy/">TENSION Study</a> @eso <a href="/WorldStrokeOrg/">World Stroke Org</a> doi: 10.1002/ana.26802.
Jesper Petersson (@jespertwi29) 's Twitter Profile Photo

Remote Ischemic Conditioning for Acute Stroke: The RESIST Randomized Clinical Trial | Cerebrovascular Disease | JAMA | JAMA Network 👏Neutral results but great study on prehospital stroke treatment! Congrats Rolf 🎉 jamanetwork.com/journals/jama/…

Ashkan Shoamanesh (@ash_shoamanesh) 's Twitter Profile Photo

The ARTESIA trial reports a 37% reduction in stroke or SE with apixaban vs. ASA in patients with device detected SCAF lasting 6m-24h. Congratulations to Jeff Healey, Stuart Connolly, & PHRI.ca Population Health Research Institute 🇨🇦 team for these landmark results. nejm.org/doi/pdf/10.105… #CardioTwitter #stroke

World Stroke Academy (@worldstrokeed) 's Twitter Profile Photo

✨Over 1000 registrants for our upcoming webinar on #CerebralSmallVesselDisease! 🫵Have you booked your seat? Our topics: 📊Epidemiology, RFs & pathophysiology 🖥️Neuroimaging and clinical implications 💊Pharmacological and lifestyle us02web.zoom.us/webinar/regist… #MeetThePanel 👇

JAMA Neurology (@jamaneuro) 's Twitter Profile Photo

Most viewed JAMA Neurology article: Is door-to-treatment time associated with improved outcomes in patients with anticoagulation-associated intracerebral hemorrhage receiving reversal interventions? ja.ma/3uKPpBn

Most viewed <a href="/JAMANeuro/">JAMA Neurology</a> article: 

Is door-to-treatment time associated with improved outcomes in patients with anticoagulation-associated intracerebral hemorrhage receiving reversal interventions?  

ja.ma/3uKPpBn
Seemant Chaturvedi (@chaturvedineuro) 's Twitter Profile Photo

ENRICH trial in NEJM shows improved outcomes for lobar ICH treated with minimally invasive surgery. Surgery not effective for basal ganglia ICH. 30 day mortality lower with surgical rx. A major development in ICH rx options World Stroke Org European Stroke Org nejm.org/doi/full/10.10…

International Journal of Stroke (@intjstroke) 's Twitter Profile Photo

🚨REVISION Trial! 👁️Does Early REperfusion therapy with intravenous alteplase help recovery of VISION in acute central retinal artery occlusion? ⭕️Adaptive design with interim analysis ⭕️Up to 422 participants to be recruited journals.sagepub.com/doi/full/10.11… Sven Poli

🚨REVISION Trial!
👁️Does Early REperfusion therapy with intravenous alteplase help recovery of VISION in acute central retinal artery occlusion?

⭕️Adaptive design with interim analysis
⭕️Up to 422 participants to be recruited

journals.sagepub.com/doi/full/10.11… <a href="/SvenPoli/">Sven Poli</a>
Bo Norrving (@bonorrving) 's Twitter Profile Photo

This is a great advocacy for stroke. Happy to be onboard Greater than stroke - I strongly recommend you to join as well! Stroke needs you

JAMA Neurology (@jamaneuro) 's Twitter Profile Photo

Most viewed in the last 7 days from JAMA Neurology: Study compares percutaneous left atrial appendage occlusion w/ continuing oral anticoagulation therapy (OAT) alone regarding stroke prevention in pts w/ AF who had a thromboembolic event despite taking OAT. ja.ma/3Bv4E4J

Most viewed in the last 7 days from <a href="/JAMANeuro/">JAMA Neurology</a>:

Study compares percutaneous left atrial appendage occlusion w/ continuing oral anticoagulation therapy (OAT) alone regarding stroke prevention in pts w/ AF who had a thromboembolic event despite taking OAT.

ja.ma/3Bv4E4J
Stephan A Mayer (@stephanamayer) 's Twitter Profile Photo

We still are overly pessimistic when assessing prognosis after #ICH In the INTERACT-3 trial Of over 6000 ICH patients physicians (75% neurosurgeons) were very accurate in Identifying who was going to die… …But massively underestimated the proportion of pts who went on to

Stephan A Mayer (@stephanamayer) 's Twitter Profile Photo

NCCT can reveal many features that predict active bleeding & hematoma expansion. Like black hole, blend, swirl, and island signs. Plus CRA spot sign. The caveat is that the scan is performed early (<2 hrs from Sx onset).

Stephan A Mayer (@stephanamayer) 's Twitter Profile Photo

The Rule of 26: In the SELECT-2 trial of EVT for large core LVO in which an overall benefit was seen, a large (>26 ml) core of severe hypodensity (<26 HU) negated the benefit of thrombectomy and was associated w/ an ⬆️ risk of hemicraniectomy ahajournals.org/doi/abs/10.116…

European Stroke Org (@esostroke) 's Twitter Profile Photo

🧠“It boosts clinical confidence & builds a strong international network.” – Prof. Simon Jung on the European Stroke Master Programme 🔗 Read the interview: eso-stroke.org/european-maste… 🗓 Apply by 31 Aug: eso-stroke.org/resources/euro… #Stroke European Stroke Master Insel Gruppe Urs Martin Fischer

🧠“It boosts clinical confidence &amp; builds a strong international network.” – Prof. Simon Jung on the European Stroke Master Programme 🔗 Read the interview: eso-stroke.org/european-maste…
🗓 Apply by 31 Aug: eso-stroke.org/resources/euro…
#Stroke <a href="/MASStroke/">European Stroke Master</a> <a href="/inselgruppe/">Insel Gruppe</a> <a href="/FishingNeurons/">Urs Martin Fischer</a>